Literature DB >> 17250722

Decreased cerebral blood flow velocity in apolipoprotein E epsilon4 allele carriers with mild cognitive impairment.

Z-W Sun1, Y-X Zhu, H-Y Liu, J Liu, X-Q Zhu, J-N Zhou, R-Y Liu.   

Abstract

The aim of this study was to investigate the changes in cerebral blood flow velocity (CBFV) and its relation to apolipoprotein E (apoE) epsilon4 allele in mild cognitive impairment (MCI). Thirty MCI and 30 controls were assessed using Mini-Mental State Examination (MMSE) and Cambridge Cognitive Examination-Chinese version (CAMCOG-C), and then insonated in the anterior (ACA), middle (MCA) and basilar (BA) cerebral arteries using transcranial Doppler ultrasonography. Compared with controls, MCI showed significant decreases in the mean (V(m)), systolic (V(s)) and diastolic (V(d)) CBFV, bilaterally in MCA and ACA (P < 0.05-0.001), but not in BA. Compared with 17 apoE epsilon4 allele non-carriers, 13 carriers in MCI showed significant CBFV decreases, bilaterally in MCA (P < 0.05-0.001). Our findings, the decreased CBFV in apoE epsilon4 allele carriers with MCI, suggest that a large sample and longitudinal study in CBFV and cognitive changes may have the implications on early diagnosis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17250722     DOI: 10.1111/j.1468-1331.2006.01579.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

Review 1.  Can Curcumin Counteract Cognitive Decline? Clinical Trial Evidence and Rationale for Combining ω-3 Fatty Acids with Curcumin.

Authors:  Julia Christina Kuszewski; Rachel Heloise Xiwen Wong; Peter Ranald Charles Howe
Journal:  Adv Nutr       Date:  2018-03-01       Impact factor: 8.701

Review 2.  The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.

Authors:  Chelsea C Hays; Zvinka Z Zlatar; Christina E Wierenga
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

Review 3.  The role of APOE in cerebrovascular dysfunction.

Authors:  Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu
Journal:  Acta Neuropathol       Date:  2016-02-16       Impact factor: 17.088

4.  Chronic effects of a wild green oat extract supplementation on cognitive performance in older adults: a randomised, double-blind, placebo-controlled, crossover trial.

Authors:  Rachel H X Wong; Peter R C Howe; Janet Bryan; Alison M Coates; Jonathan D Buckley; Narelle M Berry
Journal:  Nutrients       Date:  2012-05-03       Impact factor: 5.717

5.  Small-World Brain Network and Dynamic Functional Distribution in Patients with Subcortical Vascular Cognitive Impairment.

Authors:  Yongqiang Yu; Xia Zhou; Haibao Wang; Xiaopeng Hu; Xiaoqun Zhu; Liyan Xu; Chao Zhang; Zhongwu Sun
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

6.  Effects of Resveratrol on Cognitive Performance, Mood and Cerebrovascular Function in Post-Menopausal Women; A 14-Week Randomised Placebo-Controlled Intervention Trial.

Authors:  Hamish M Evans; Peter R C Howe; Rachel H X Wong
Journal:  Nutrients       Date:  2017-01-03       Impact factor: 5.717

Review 7.  Effects of Long-Chain Omega-3 Polyunsaturated Fatty Acids on Endothelial Vasodilator Function and Cognition-Are They Interrelated?

Authors:  Julia C Kuszewski; Rachel H X Wong; Peter R C Howe
Journal:  Nutrients       Date:  2017-05-12       Impact factor: 5.717

8.  Apolipoprotein E4 effects on topological brain network organization in mild cognitive impairment.

Authors:  Gretel Sanabria-Diaz; Lester Melie-Garcia; Bogdan Draganski; Jean-Francois Demonet; Ferath Kherif
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 9.  Neurosonological Examination: A Non-Invasive Approach for the Detection of Cerebrovascular Impairment in AD.

Authors:  Barbora Urbanova; Ales Tomek; Robert Mikulik; Hana Magerova; Daniel Horinek; Jakub Hort
Journal:  Front Behav Neurosci       Date:  2014-01-21       Impact factor: 3.558

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.